Clinical Trials at Staten Island University Hospital
As of August 2026, 13 paid clinical trials are recruiting at Staten Island University Hospital, located at 475 SEAVIEW AVE, STATEN ISLAND, NY 10305-3436, phone (718) 226-4502 in Staten Island, New York. Active studies at this site cover conditions such as Schizophrenia, Major Depressive Disorder and Anatomic Stage II Breast Cancer AJCC v8. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
View the full facility profile →
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Staten Island
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
14 clinical trials at Staten Island University Hospital
·Clear filters·A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Does Batten Grafting Improve Nasal Outcomes in Septoplasty and Turbinate Reduction?
Common conditions studied in Staten Island
- Schizophrenia (7 active studies)
- Major Depressive Disorder (6 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Autism Spectrum Disorder (3 active studies)
- Irritability Associated With Autism Spectrum Disorder (3 active studies)
- Major Depressive Disorder (MDD) (3 active studies)
Leading research sponsors in Staten Island
- Bristol-Myers Squibb
- NRG Oncology
- Northwell Health
- AstraZeneca
- Intra-Cellular Therapies, Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Staten Island?
There are approximately 77 recruiting clinical trials in Staten Island, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Staten Island pay participants?
Most recruiting trials in Staten Island compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Staten Island?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Staten Island?
The most common conditions under active study in Staten Island include Schizophrenia (7), Major Depressive Disorder (6), Anatomic Stage II Breast Cancer AJCC v8 (4), Autism Spectrum Disorder (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Staten Island?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Staten Island on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Staten Island?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Staten Island?
Recruiting research sites in Staten Island include Staten Island University Hospital, Richmond Behavioral Associates, Richmond University Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Staten Island right now?
The largest active categories in Staten Island are Cancer & tumors (13), Mental health & behavior (12), Cardiovascular (9). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Staten Island University Hospital?
Staten Island University Hospital is located at 475 SEAVIEW AVE, STATEN ISLAND, NY 10305-3436. Use the Google Maps link in the intro above to get directions.
How do I contact Staten Island University Hospital?
You can reach Staten Island University Hospital by phone at (718) 226-4502. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.